Meeder Advisory Services’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.79M Sell
8,214
-247
-3% -$125K 0.16% 90
2025
Q4
$4.79M Buy
8,461
+720
+9% +$383K 0.21% 72
2025
Q3
$3.46M Sell
7,741
-776
-9% -$372K 0.16% 99
2025
Q2
$4.63M Buy
8,517
+436
+5% +$228K 0.24% 62
2025
Q1
$4M Buy
8,081
+331
+4% +$183K 0.24% 64
2024
Q4
$4.05M Buy
7,750
+364
+5% +$190K 0.25% 57
2024
Q3
$3.63M Buy
7,386
+22
+0.3% +$10.2K 0.23% 69
2024
Q2
$3.28M Buy
7,364
+1,889
+35% +$752K 0.23% 73
2024
Q1
$2.19M Buy
5,475
+288
+6% +$109K 0.22% 75
2023
Q4
$1.75M Buy
5,187
+426
+9% +$127K 0.2% 83
2023
Q3
$1.39M Sell
4,761
-934
-16% -$292K 0.17% 98
2023
Q2
$1.95M Buy
5,695
+219
+4% +$66.3K 0.21% 84
2023
Q1
$1.4M Buy
5,476
+63
+1% +$15.5K 0.16% 109
2022
Q4
$1.44M Buy
+5,413
New +$1.32M 0.18% 96

Other funds holding ISRG

Meeder Advisory Services's ISRG Position: Q1 2026 in Review

Meeder Advisory Services reduced its Intuitive Surgical (ISRG) stake by 2.9% in Q1 2026, selling an estimated $125K and leaving 8,214 shares worth $3.79M. The position accounts for 0.16% of the portfolio, ranked #90.

Meeder Advisory Services first reported a position in ISRG in Q4 2022 and has held it in 14 quarters since. The position peaked at $4.79M in Q4 2025. 2,302 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • Meeder Advisory Services held 8,214 shares of Intuitive Surgical worth $3.79M as of Q1 2026.
  • Meeder Advisory Services sold 247 Intuitive Surgical shares in Q1 2026, an estimated $125K.
  • Intuitive Surgical made up 0.16% of Meeder Advisory Services's portfolio in Q1 2026, its #90 holding.
  • Meeder Advisory Services first reported a position in Intuitive Surgical in Q4 2022 and has held it in 14 quarters since.
  • Meeder Advisory Services's Intuitive Surgical position peaked at $4.79M in Q4 2025.
  • 2,302 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on Meeder Advisory Services's 13F filing for Q1 2026, filed 7 May 2026.